What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Oliver FitzGerald mainly focuses on Psoriatic arthritis, Arthritis, Internal medicine, Psoriasis and Rheumatoid arthritis.
Psoriatic arthritis is a subfield of Immunology that Oliver FitzGerald studies.
His studies deal with areas such as Psoriasis Area and Severity Index and Antigen as well as Arthritis.
His research in Internal medicine intersects with topics in Gastroenterology and Endocrinology.
His Psoriasis research includes themes of Genome-wide association study, Genetic association and Single-nucleotide polymorphism.
His Rheumatoid arthritis research is multidisciplinary, incorporating perspectives in Erythrocyte sedimentation rate, Autoimmune disease and Immunopathology, Pathology.
His most cited work include:
- A Genome-Wide Association Study Identifies New Psoriasis Susceptibility Loci and an Interaction Between HLA-C and ERAP1 (768 citations)
- Correction: Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis (679 citations)
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (644 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Psoriatic arthritis, Rheumatoid arthritis, Rheumatology and Physical therapy are his primary areas of study.
His work on Inflammatory arthritis as part of general Internal medicine research is often related to In patient, thus linking different fields of science.
Oliver FitzGerald is investigating Psoriasis, Arthritis, Immunology, Disease and Dermatology as part of his examination of Psoriatic arthritis.
Enthesitis and Dactylitis are among the areas of Psoriasis where the researcher is concentrating his efforts.
The study incorporates disciplines such as Biomarker, Autoimmune disease and Immunopathology, Pathology in addition to Rheumatoid arthritis.
His Physical therapy research incorporates themes from Observational study, Quality of life, Randomized controlled trial, Ankylosing spondylitis and Cohort.
He most often published in these fields:
- Internal medicine (48.79%)
- Psoriatic arthritis (44.46%)
- Rheumatoid arthritis (24.57%)
What were the highlights of his more recent work (between 2017-2021)?
- Psoriatic arthritis (44.46%)
- Internal medicine (48.79%)
- Psoriasis (20.59%)
In recent papers he was focusing on the following fields of study:
His main research concerns Psoriatic arthritis, Internal medicine, Psoriasis, In patient and Rheumatology.
His Psoriatic arthritis study is concerned with the larger field of Disease.
The Internal medicine study combines topics in areas such as Placebo and Oncology.
The various areas that he examines in his Psoriasis study include Family medicine and MEDLINE.
His Rheumatology study combines topics in areas such as Pregnancy, Systemic inflammation, Breastfeeding and Reproductive health.
Many of his research projects under Rheumatoid arthritis are closely connected to Rapid response with Rapid response, tying the diverse disciplines of science together.
Between 2017 and 2021, his most popular works were:
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (260 citations)
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. (52 citations)
- Higher Coronary Plaque Burden in Psoriatic Arthritis Is Independent of Metabolic Syndrome and Associated With Underlying Disease Severity. (26 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Oliver FitzGerald mainly investigates Psoriatic arthritis, Internal medicine, Rheumatology, Physical therapy and Randomized controlled trial.
His biological study spans a wide range of topics, including Clinical trial, Systematic review, Adverse effect, Quality of life and Ankylosing spondylitis.
His research investigates the connection between Internal medicine and topics such as Placebo that intersect with issues in Psoriasis Area and Severity Index and Certolizumab pegol.
His work carried out in the field of Rheumatology brings together such families of science as Psoriasis, Triage and Referral.
Oliver FitzGerald has researched Psoriasis in several fields, including Artery and Family medicine.
The concepts of his Physical therapy study are interwoven with issues in Epidemiology and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
